Pharvaris (PHVS) Accumulated Expenses (2019 - 2026)

Pharvaris (PHVS) has 8 years of Accumulated Expenses data on file, last reported at $22.3 million in Q1 2026.

• Quarterly Accumulated Expenses rose 23.5% year-over-year to $22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.3 million (up 23.5% YoY) and the FY2025 annual result came in at $26.4 million, up 38.57% from the prior year.
• Accumulated Expenses slipped to $22.3 million in Q1 2026, from $27.2 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $27.2 million in Q4 2025 to a low of $7.3 million in Q1 2022.
• A 5-year average of $15.5 million and a median of $13.2 million in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses surged 137.53% — and 2024, when it rose 6.07%.
• Tracing PHVS's Accumulated Expenses over 5 years: stood at $11.1 million in 2022, then gained by 7.17% to $11.9 million in 2023, then soared by 57.83% to $18.8 million in 2024, then soared by 44.61% to $27.2 million in 2025, then declined by 17.96% to $22.3 million in 2026.
• The last three Accumulated Expenses figures came in at $22.3 million (Q1 2026), $27.2 million (Q4 2025), and $26.5 million (Q3 2025), per Business Quant data.